Wanbury Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

284.49

-5.23 (-1.81%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

284.49

-5.23 (-1.81%)
16:02 Dec 20

Quality

55/100
High Financial Strength

Valuation

42/100
Mid Valuation

Technical

68/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	392.52	511.19	499.65	575.65	577.21
Operating Expenses +	374.51	475.87	476.48	505.65	506.92
Raw Material	224.35	325.07	273.46	306.52	288.71
Increase Decrease in Cost	-7.2	-24.79	29.13	-3.89	0.83
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	64.15	74.81	81	86.92	96.27
Miscellaneous Expenses	114.51	141.06	124.85	150.7	121.11
Operating Profit	18.01	35.32	23.17	70	70.29
Other Income	2.4	1.51	0.91	2.99	4.19
Depreciation	9.75	11.45	12.38	13.03	13.21
Interest	23.07	20.61	21.39	29.18	33.46
Profit before tax and exceptio..	-12.41	4.76	-9.69	30.78	27.81
Exceptional Items	0	76.37	-0.59	25.56	25.56
PBT	-12.41	81.13	-10.29	56.34	2.25
Provision for Taxation	0.2	-0.35	0.11	0.38	0.4
Net Profit	-12.61	81.47	-10.4	55.96	52.96
NET Profit after MI	-12.61	81.47	-10.4	55.96	52.96
EPS	-5.04	25.29	-3.18	17.1	16.17
Operating Profit Margin (%)	4.59	6.91	4.64	12.16	12.18
Net Profit Margin (%)	-3.21	15.94	-2.08	9.72	9.18

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	39.80	39.80	39.80	39.80	39.80
FII	1.00	0.20	0.20	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	59.20	60.00	60.00	60.10	60.10
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.10	0.10